Into the Fourth Dimension: Dysregulation of Genome Architecture in Aging and Alzheimer’s Disease

Frontiers in Molecular Neuroscience

Warren Winick-Ng¹  R. Jane Rylett² 

[1] Dentistry, University of Western Ontario, London, ON, Canada;;Department of Physiology and Pharmacology, Schulich School of Medicine &Molecular Medicine Research Laboratories, Robarts Research Institute, University of Western Ontario, London, ON, Canada;

关键词: Alzheimer’s disease;    epigenetics;    gene regulation;    genome architecture;    protein mislocalization;   

DOI  :  10.3389/fnmol.2018.00060

来源: DOAJ

【 摘 要 】

Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by synapse dysfunction and cognitive impairment. Understanding the development and progression of AD is challenging, as the disease is highly complex and multifactorial. Both environmental and genetic factors play a role in AD pathogenesis, highlighted by observations of complex DNA modifications at the single gene level, and by new evidence that also implicates changes in genome architecture in AD patients. The four-dimensional structure of chromatin in space and time is essential for context-dependent regulation of gene expression in post-mitotic neurons. Dysregulation of epigenetic processes have been observed in the aging brain and in patients with AD, though there is not yet agreement on the impact of these changes on transcription. New evidence shows that proteins involved in genome organization have altered expression and localization in the AD brain, suggesting that the genomic landscape may play a critical role in the development of AD. This review discusses the role of the chromatin organizers and epigenetic modifiers in post-mitotic cells, the aging brain, and in the development and progression of AD. How these new insights can be used to help determine disease risk and inform treatment strategies will also be discussed.

【 授权许可】

Unknown